ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $786,982 | +4.7% | 43,843 | +18.5% | 0.00% | 0.0% |
| Q2 2023 | $751,592 | +5.6% | 37,006 | -5.2% | 0.00% | 0.0% |
| Q1 2023 | $711,707 | -20.7% | 39,019 | -10.1% | 0.00% | -33.3% |
| Q4 2022 | $897,471 | -21.5% | 43,398 | -0.8% | 0.00% | -25.0% |
| Q3 2022 | $1,144,000 | +6.5% | 43,730 | +3.2% | 0.00% | +33.3% |
| Q2 2022 | $1,074,000 | -40.0% | 42,385 | -25.2% | 0.00% | -25.0% |
| Q1 2022 | $1,789,000 | -31.7% | 56,700 | -12.4% | 0.00% | -20.0% |
| Q4 2021 | $2,618,000 | +32.4% | 64,700 | +14.1% | 0.01% | +25.0% |
| Q3 2021 | $1,977,000 | +27.0% | 56,700 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $1,557,000 | -18.6% | 56,700 | -16.7% | 0.00% | -25.0% |
| Q1 2021 | $1,912,000 | -70.0% | 68,100 | -72.2% | 0.00% | -73.3% |
| Q4 2020 | $6,368,000 | +49.7% | 245,300 | -1.2% | 0.02% | +36.4% |
| Q3 2020 | $4,254,000 | +220.1% | 248,200 | +362.2% | 0.01% | +175.0% |
| Q2 2020 | $1,329,000 | +91.2% | 53,700 | +7.2% | 0.00% | +100.0% |
| Q1 2020 | $695,000 | +45.4% | 50,100 | +5.9% | 0.00% | +100.0% |
| Q4 2019 | $478,000 | +11.2% | 47,300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $430,000 | +25.0% | 47,300 | +9.2% | 0.00% | 0.0% |
| Q2 2019 | $344,000 | -34.8% | 43,300 | +2.4% | 0.00% | -50.0% |
| Q1 2019 | $528,000 | – | 42,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |